A Promoter Competition Hub Orchestrates Runx1 Alternative Promoter Usage during Skeletal Muscle Stem Cell Activation
This study reveals that a dynamic promoter competition hub, orchestrated by the transcription factor USF1 within a multi-connected enhancer-promoter loop, governs stage-specific alternative promoter usage of the Runx1 gene to regulate skeletal muscle stem cell activation and proliferation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the body's repair crew, skeletal muscle stem cells lie dormant until an injury wakes them up. These cells must then switch from a resting state to an active one, dividing rapidly to rebuild damaged tissue before settling down again. For this transformation to happen, the cells need to turn specific genes on and off with perfect timing. One such gene, known as Runx1, acts as a critical switchboard. Like many genes, Runx1 has two different starting points, or promoters, where the cell's machinery can begin reading the genetic instructions. One starting point is used early in the repair process, while the other is used later. The big question for scientists has been how the cell decides which starting point to use and how it switches between them without getting confused.
Researchers at The Chinese University of Hong Kong and other institutions have now uncovered the mechanism behind this switch. They discovered that the two starting points of the Runx1 gene do not simply take turns; they actively compete with each other for access to a shared set of regulatory switches called enhancers. These enhancers are like remote controls that tell the gene when to turn on. The study reveals that the two starting points are locked in a tug-of-war within a three-dimensional loop of DNA. When the cell needs to activate, the first starting point grabs the enhancers. As the cell moves into the next phase of repair, a specific protein called USF1 binds to the second starting point, helping it pull the enhancers away from the first one. This competition ensures that the correct version of the Runx1 protein is made at exactly the right moment for the muscle to heal.
To understand how this works, the team looked at muscle stem cells from mice, both in a lab dish and inside living animals. They observed that when the cells first wake up after an injury, they use the first starting point to produce a version of the Runx1 protein that helps the cells begin to divide. As the cells continue to multiply, the first starting point shuts down, and the second one takes over to produce a different version of the protein that supports rapid growth. The researchers found that if they blocked the first starting point, the cells could not wake up properly. If they blocked the second, the cells woke up but could not multiply enough to repair the muscle. This showed that each starting point has a unique and non-interchangeable job.
The scientists then investigated how the cell manages this switch. They found that the two starting points and their shared enhancers form a tight cluster, or hub, in the three-dimensional space of the cell's nucleus. In this hub, the two starting points fight for the same enhancers. When the first starting point is active, it holds onto the enhancers. But as the cell progresses, a protein called USF1 binds directly to the second starting point. This binding acts as a lever, helping the second starting point win the competition and pull the enhancers toward itself. This physical rewiring of the DNA loop changes which version of the gene is turned on. The researchers tested this by removing the USF1 protein; without it, the second starting point could not grab the enhancers, and the muscle cells failed to multiply, leading to poor muscle repair.
Interestingly, the team also checked if a well-known protein called CTCF, which usually acts as a barrier to keep gene regions separate, was involved in this competition. They found that even when they removed the CTCF binding sites near the gene, the competition between the two starting points continued unchanged. This ruled out CTCF as the main driver and pointed squarely at USF1 as the key orchestrator. The study further showed that this competition is not unique to Runx1. By looking at thousands of other genes in muscle stem cells, they found that many genes use a similar strategy, where two starting points compete for enhancers to ensure precise timing during cell development.
The findings suggest that the three-dimensional architecture of the genome is not just a static scaffold but a dynamic arena where gene regulation happens through physical competition. By identifying USF1 as the factor that tips the balance, the researchers have revealed a fundamental principle of how cells navigate complex life stages. This work provides a clear view of how a single gene can produce different outcomes at different times, ensuring that muscle stem cells know exactly when to start working and when to keep working, a process that is essential for the body's ability to heal itself.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.